From a study of different ApoA proteins, a recent meta-analysis based on 17 case-control-, two cohort-, and three combined case-control studies (a total of 207 AD and mild cognitive) showed that ApoA-I decreased in AD, while ApoAIV increased [55], which partially supports the current findings. The gene discussed is APOA4; the disease is Alzheimer disease.